Vulnerability Description
Unspecified vulnerability in Oracle Pharmaceutical Applications 4.5.1 has unknown impact and remote authenticated attack vectors, aka Vuln# PHAR01.
CVSS Score
HIGH
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Oracle | Pharmaceutical | 4.5.1 |
References
- http://secunia.com/advisories/22396
- http://securitytracker.com/id?1017077
- http://www.oracle.com/technetwork/topics/security/cpuoct2006-095368.html
- http://www.red-database-security.com/advisory/oracle_cpu_oct_2006.html
- http://www.securityfocus.com/archive/1/449711/100/0/threaded
- http://www.securityfocus.com/bid/20588Patch
- http://www.us-cert.gov/cas/techalerts/TA06-291A.htmlUS Government Resource
- http://www.vupen.com/english/advisories/2006/4065
- http://secunia.com/advisories/22396
- http://securitytracker.com/id?1017077
- http://www.oracle.com/technetwork/topics/security/cpuoct2006-095368.html
- http://www.red-database-security.com/advisory/oracle_cpu_oct_2006.html
- http://www.securityfocus.com/archive/1/449711/100/0/threaded
- http://www.securityfocus.com/bid/20588Patch
- http://www.us-cert.gov/cas/techalerts/TA06-291A.htmlUS Government Resource
FAQ
What is CVE-2006-5374?
CVE-2006-5374 is a vulnerability with a CVSS score of 10.0 (HIGH). Unspecified vulnerability in Oracle Pharmaceutical Applications 4.5.1 has unknown impact and remote authenticated attack vectors, aka Vuln# PHAR01.
How severe is CVE-2006-5374?
CVE-2006-5374 has been rated HIGH with a CVSS base score of 10.0/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2006-5374?
Check the references section above for vendor advisories and patch information. Affected products include: Oracle Pharmaceutical.